USBC, Inc.
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Feb 14, 2025
USBC$0.37-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Deficit
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY
Unaudited
| Series C Convertible · Series D Convertible · Additional · TotalStockholders' | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Preferred Stock · Common Stock · Paid in · Accumulated · Equity/ | |||||||||
| Shares | $ | Shares | $ | Shares | $ | Capital | Deficit | (Deficit) | |
| Balance as of October 1, 2023 | 17,858 | $1,790 | 10,161 | $1,015 | 80,358,463 | $80,358 | $125,501,537 | $(121,840,788) | $3,743,912 |
| Stock compensation expense - employee options | - | - | - | - | - | - | 699,246 | - | 699,246 |
| Issuance of common stock for services | - | - | - | - | 105,000 | 105 | 26,145 | - | 26,250 |
| Deemed dividends on Series C and D Preferred Stock | - | - | - | - | - | - | 63,629 | (63,629) | - |
| Isssuance of common stock for common stock offering | - | - | - | - | 883,061 | 884 | 202,221 | - | 203,105 |
| Net loss | - | - | - | - | - | - | - | (3,446,624) | (3,446,624) |
| Balance as of December 31, 2023 | 17,858 | 1,790 | 10,161 | 1,015 | 81,346,524 | 81,347 | 126,492,778 | (125,351,041) | 1,225,889 |
| Balance as of October 1, 2024 | 17,858 | $1,790 | 10,161 | $1,015 | 108,097,936 | $108,021 | $136,468,855 | $(138,735,882) | $(2,156,201) |
| Stock compensation expense - employee options | - | - | - | - | - | - | 550,703 | - | 550,703 |
| Deemed dividends on Series C and D Preferred Stock | - | - | - | - | - | - | 32,552 | (32,552) | - |
| Isssuance of common stock for common stock offering | - | - | - | - | 1,250,000 | 1,250 | 298,750 | - | 300,000 |
| Issuance of common stock for debt payment | - | - | - | - | 1,818,181 | 1,818 | 238,182 | - | 240,000 |
| Repricing of convertible notes payable and warrants | - | - | - | - | - | - | 1,302,607 | - | 1,302,607 |
| Extension of warrants | - | - | - | - | - | - | 513,499 | - | 513,499 |
| Net loss | - | - | - | - | - | - | - | (4,665,508) | (4,665,508) |
| Balance as of December 31, 2024 | 17,858 | $1,790 | 10,161 | $1,015 | 111,166,117 | $111,089 | $139,405,148 | $(143,433,942) | $(3,914,900) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.